Illumina s Q4 Revenues Surge on Strong Sales, Net Losses Narrow

Jan 27, 2004

NEW YORK, Jan. 27 (GenomeWeb News) - Illumina today reported a 176 percent increase in revenues for its fourth fiscal quarter, accompanied by diminishing net losses and a slight decrease in R&D spending.

For the quarter ended Dec. 28, 2003, Illumina reported revenue of $10.7 million, compared to $3.9 million for the fourth quarter of 2002.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Diving into Gene-Editing Data

The Wall Street Journal reports there is uncertainty surrounding whether He Jiankui's embryo editing did what he said it did.

Scramble for Tissue

Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.

Weigh the Knowledge

Customers might want to consider what they might learn about their risk of diseases like Alzheimer's before snagging the genetic testing kits that are on many gift guides this year, NJ.com writes.

This Week in Nature

In Nature this week: genomic analysis of the invasive fall webworm, amp of constrained coding regions within the human genome, and more.

Main menu